Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Opteev Technologies is a Baltimore-based health technology company focused on the development of rapid, non-invasive diagnostic tools for respiratory infections. The company's core innovation is the ViraWarn breathalyzer, which utilizes proprietary multi-antigen biosensor technology to detect COVID-19, Influenza, and RSV in less than a minute. Designed for both consumer and clinical environments, the device offers a reusable and cost-effective alternative to traditional swab-based antigen tests. Opteev's platform integrates advanced biotechnology with electronic sensing to provide real-time screening results. The company aims to enhance public safety and pandemic preparedness through accessible point-of-care diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Opteev Technologies.